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Benzene’s Adverse Effects
Microarrays Reveal Breadth of Toxicity
Benzene is both widely used and widely studied. Yet, although the
chemical is strongly associated with leukemia in humans, questions
remain regarding its mechanism of action. Hoping to better under-
stand the genetic mechanisms behind benzene’s hematotoxicity
and leukemogenicity, a group of researchers from Japan and Korea
used cDNA microarrays to analyze mouse bone marrow tissue
both during and after a two-week exposure to the compound by
inhalation [EHP 111:1411–1420]. The researchers found, among
other discoveries, that benzene may perturb cell cycling that is
mediated by the gene for the protein p53, triggering a host of fatal
problems at the cellular level and thus causing blood cell malignan-
cies epigenetically (that is, without encoding the information in
the genetic code). 
Benzene is used in fuels, as an industrial solvent, and in other
manufacturing applications, and is also found in cigarette smoke.
Human populations generally are exposed through polluted ambi-
ent air or contaminated water. Benzene is known to cause hemato-
toxicity and blood tumors in humans and mice. Studies so far have
focused on benzene’s carcinogenic and genotoxic metabolites,
which cause various types of tumors in a number of mouse organ
systems. Hepatic enzymes convert inhaled benzene into genotoxic
metabolites. Then, to add insult to injury, a number of these ben-
zene metabolites (primarily phenol, hydroquinone, catechol, and
trans-trans muconic acid) actually intensify the chemical’s toxic
effect on an organ. 
Past studies have suggested that benzene’s toxic effects on bone
marrow tissue—its major target organ—may be enacted through
multiple pathways, including growth factor regulation, oxidative
stress reduction, DNA damage repair, cell cycle regulation, and
apoptosis. Also, genetic variations may upset the cellular–environ-
mental homeostasis that protects bone marrow cells from toxic
effects such as those caused by benzene, resulting in altered gene
expression. Therefore, the authors suggest, studying just a few spe-
cific genes may not be enough to thoroughly explain the complex
molecular mechanisms of benzene-induced hematotoxicity and
leukemogenicity. 
With this in mind, the research team conducted broad cDNA
microarray analyses using multiple gene expression profiling tech-
nologies. The team analyzed mouse bone marrow tissue during and
after exposure to 300 parts per million benzene over a 2-week peri-
od for 6 hours a day, 5 days a week. Two types of C57BL/6 mice
were used—standard wild-type mice possessing the gene for p53
and p53-knockout mice. The mice were randomly grouped into
control and benzene-exposed groups. 
Twice during the exposure period and then 3
days after the full 2-week exposure, the
researchers collected bone marrow from both
femurs of each mouse in each group. RNA was
extracted from this tissue and used to synthesize
cDNA, which was then hybridized onto a
microarray chip. The resulting array of gene frag-
ments was scanned as a digital image and ana-
lyzed using software that searched for clustering
genes specifically expressed and/or suppressed in
each group.
The researchers found that benzene caused
DNA damage in cells during all phases of the cell
cycle. In the benzene-exposed wild-type mice,
DNA repair genes were activated, but they were
suppressed in the p53-knockout mice. Mice in
the latter group were therefore susceptible to ben-
zene’s direct genotoxic leukemogenicity, whereas
those in the former still experienced epigenetic
leukemogenicity via cell-cycle perturbations
despite DNA repair.
Besides the p53-mediated pathway, the inves-
tigators identified other specific genes that may
be involved in G1 cell cycle arrest and apoptosis
following benzene exposure, and confirmed that
certain repair genes—including the tuberous scle-
rosis gene and the metallothionein 1 gene—are
also triggered by such exposure. They also found
that, during benzene exposure, the production of
blood cells was arrested due to alterations in the
expression of cell cycle checkpoint genes in the
wild-type mice. However, production continued
in the p53-knockout mice, an important differ-
ence that the researchers say could point to mech-
anisms of benzene’s hematotoxicity. 
The researchers’ cDNA microarray analyses
supported the theory that the gene for p53 medi-
ates the effect of benzene on bone marrow tissue
by regulating specific genes instrumental in cell
cycle arrest, apoptosis, and DNA repair. Because
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A bad actor in blood. New research shows that benzene’s toxic effects—including leuke-
mogenicity and hematotoxicity—are wrought through many pathways. Thus, multiple genes
may be implicated.Science Selections
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careful simultaneous screening of different expression patterns of
many interrelated genes between the two groups is necessary, the
researchers write, toxicogenomics should prove extremely useful for
future investigations into the toxicity and leukemogenicity mecha-
nisms of benzene. –Jennifer Medlin
Effect of SNPs on OPs
Age and Race Variations Explored
Newborns produce substantially less of the enzyme paraoxonase-1
(PON1)—which detoxifies organophosphate pesticides—than do
adults, potentially leaving them more vulnerable to organophos-
phate exposures. Genetic differences in PON1 activity are also
more pronounced in newborns than in adults, according to recent
research by Jia Chen and colleagues at the Mount Sinai School of
Medicine [EHP 111:1403–1409]. By helping to determine which
groups are most susceptible based on age and genetic factors, these
results may have implications for setting exposure standards.
Metabolites of organophosphates damage the nervous systems
of insects and humans by reducing the ability of the enzyme
cholinesterase to regulate the electrochemical signals between neu-
rons. When cholinesterase levels drop, neurons become overstimu-
lated and send repeat signals that can eventually cause muscle
weakness, paralysis, and death. PON1 breaks down organophos-
phates before they can cause nerve damage.
The current study is part of ongoing research on the neuro-
developmental risks posed by exposure to the organophosphate
pesticide chlorpyrifos among an inner-city population in New
York City. Once among the most commonly used insecticides,
chlorpyrifos was banned in 2000 for many residential uses in the
United States because of concern over children’s health. Like other
organophosphates, chlorpyrifos and its toxic metabolite chlorpyri-
fos oxon can cross the placenta. Therefore, exposures by pregnant
women can affect their unborn children. However, little is known
about the effects of low-level
exposures on children’s develop-
ment, including their ability to
learn later in life. Chlorpyrifos is
still approved for many agricultur-
al uses, and children in rural areas
continue to be exposed. 
Researchers have identified
five single-nucleotide polymor-
phisms that affect PON1 produc-
tion, three in the promoter region
of the PON1 gene (–909, –162,
–108) and two in the coding
region (L55M, Q192R). PON1
has also been linked to, or tends
to be inherited along with, two
other genes, PON2 and PON3.
From March 1998 through
March 2002, the Mount Sinai
researchers genotyped and mea-
sured PON1 activity in the blood
of an ethnically diverse group of
402 expectant mothers and 229
newborns. Participants identified
themselves, or were identified by
their parents, as Caucasian (82
mothers, 56 newborns), African
American (117 mothers, 66 new-
borns), or Caribbean Hispanic
(203 mothers, 107 newborns). Blood samples were genotyped for
the five PON1 polymorphisms. Because the researchers are also
studying the linkage of PON genes, samples were also genotyped
for a common PON2 polymorphism (C311S). The level of PON1
activity in each blood sample was determined by an assay that mea-
sures hydrolysis of phenylacetate. 
As expected, the results showed that PON1 activity of new-
borns was less than that of adults, and so newborns are potential-
ly more susceptible to the effects of chlorpyrifos exposure. In
addition, the Mount Sinai researchers found that some groups of
newborns may be more vulnerable than others. The presence of
PON1 polymorphisms and PON1 activity varied among
racial/ethnic groups. PON1 activity in the blood of the expectant
mothers was 4.6, 3.6, and 2.6 times greater than in that of new-
borns for Caucasians, Caribbean Hispanics, and African
Americans, respectively. In addition, the impact of genetic vari-
ability was greater in the newborns than in the adults. None of
the polymorphisms affected PON1 activity in the women by
more than 35%. However, among the newborns, several of the
polymorphisms affected PON1 activity by as much as 200%. For
example, Caucasian infants with the CC polymorphism of the
–108 PON1 promoter had, on average, more than twice the
PON1 activity of infants with the TT polymorphism. 
The researchers further found that the polymorphisms tended
to be inherited in predictable patterns, a phenomenon referred to
as “linkage disequilibrium.” There was significant linkage disequi-
librium among the three promoter polymorphisms, and among the
promoter polymorphisms and the coding polymorphism L55M.
These relationships were strongest for Caucasian participants and
weakest for African-American participants. In addition, there was
significant linkage disequilibrium among the PON1 promoter
polymorphisms and the PON2 polymorphism C311S. These
results may contribute to a better understanding of rates of recom-
bination in genes, as well as provide a basis for future epidemiolog-
ical studies. –Kris Freeman
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e Separate at birth. New data reveal racial differences in PON1 activity in newborns. This means some infants may
be more vulnerable than others to the effects of organophosphates, which are broken down by this enzyme.